Moderna (MRNA) Return on Assets (2019 - 2026)
Moderna (MRNA) posted quarterly Return on Assets of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 4.71% on a QoQ basis from 0.0% in Q1 2026.
Moderna (MRNA) Return on Assets (2019 - 2026) Analysis & Trends
Moderna has reported Return on Assets for 8 years, with the latest figure at 0.0% in Q2 2026.
- Return on Assets for Q2 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets fell to 0.0% in Q2 2026, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q1 2022 and troughed at 0.0% in Q2 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
- The widest annual swing landed in 2022, when Return on Assets grew 1 bps; it then fell 1 bps in 2023.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then sank by 177 bps to 0.0% in 2023, then climbed by 4 bps to 0.0% in 2024, then climbed by 3 bps to 0.0% in 2025, then fell by 22 bps to 0.0% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.00% |